Search clinical trials for: ON101

Total 9 results

Oneness Biotech Co., Ltd.

Active, not recruiting

Retrospective Record-review Study in Patients Who Had Diabetic Foot Ulcer

Diabetic Foot Ulcer

Taiwan
Oneness Biotech Co., Ltd.
China Medical University Hospital

Terminated

Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)

Diabetic Foot Ulcer (DFU)

Taiwan
Oneness Biotech Co., Ltd.
Taipei Veterans General Hospital, Taiwan; Taipei Medical University Shuang...

Recruiting

A Research Study to Evaluate the Safety and Potential Efficacy of ON101 Cream for the Treatment of Venous Leg Ulcers.

Venous Leg Ulcers (VLU)

Taiwan
National Defense Medical Center, Taiwan

Completed

Explore the Short- and Mid-term Effects of Fespixon in Scar Cosmesis Following Cervical or Abdominal Surgery

Scar

Taiwan
Oneness Biotech Co., Ltd.

Completed

A Randomized,Double-blind,Placebo-controlled Clinical Study to Explore the Mechanism of Action of ON101 Cream in Patients With DFUs.

Diabetic Foot Ulcers

Taiwan
Taipei Medical University WanFang Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital; Oneness Biotech Co...

Terminated

Open-label Study to Evaluate the Efficacy and Safety of Fespixon Cream for the Treatment of Pressure Injury in Sacrum and Greater Trochanter Wound

Pressure Injury Stage 2

Taiwan
Cathay General Hospital
Oneness Biotech Co., Ltd.

Completed

Fespixon Cream for the Treatment of Chronic Diabetic Foot Ulcers (TEXAS 1A, 2A) in Dialysis Patients

Chronic Diabetic Foot Ulcer

Taiwan
Oneness Biotech Co., Ltd.

Recruiting

Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

Chronic Diabetic Foot Ulcers

United States
Oneness Biotech Co., Ltd.

Completed

Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

Diabetic Foot

Taiwan, China, United States

3

Subscribe